Arm Holdings is trading at $257.54, down 3.28%, with the Qualcomm licensing dispute a potential pressure point for royalty income.

  • In the Delaware jury trial, Qualcomm seeks relief that could affect royalty payments; no verdict had been reached as of October 9, and a decision remains pending.
  • Coverage does not prove the litigation directly caused the October 12 intraday decline; broader indices were nearly flat, and Marvell’s CXL announcement is not evidence of a direct Arm catalyst.